Lymphomas & Lymphoid Neoplasia

Lymphomas & Lymphoid Neoplasia

A collection of features and news articles published in ASH Clinical News related to lymphomas and lymphoid neoplasia.

Tazemetostat Granted Priority Review for Relapsed/Refractory Follicular Lymphoma

The FDA granted a priority review to the new drug application (NDA) for tazemetostat for the treatment of patients with relapsed or refractory follicular...

CAR T-Cell Therapy KTE-X19 Granted Priority Review for MCL

The FDA granted priority-review designation to the investigational chimeric antigen receptor (CAR) T-cell therapy KTE-X19 for the treatment of adults with relapsed or refractory...
WIB_icon

Avadomide Shows Promising Clinical Activity and Tolerability in Relapsed/Refractory DLBCL

Avadomide monotherapy demonstrated preliminary clinical efficacy in patients with relapsed and refractory diffuse large B-cell lymphoma (DLBCL), according to results from a phase I...

The Year in FDA Approvals

In the past year, the FDA approved a record-breaking number of drugs, several of which were indicated for the treatment of lymphoid and plasma...
On location

Can Patients With Limited-Stage Diffuse Large B-Cell Lymphoma Skip Radiation Therapy?

Results from the Intergroup National Clinical Trials Network (NCTN) study S1001 demonstrated that 89% of patients with limited-stage diffuse large B-cell lymphoma (DLBCL) maintained...
You Make the Call

Reader Responses: What is the best consolidation therapy for this patient with primary central...

Here’s how readers responded to a You Make the Call question about the treatment of primary central nervous system lymphoma. Disclaimer: ASH does not recommend...

Outcomes With Idelalisib Differ in the Clinical Trial Versus Real-World Setting

According to a real-world analysis published in JAMA Oncology, treatment outcomes with idelalisib differed between patients with follicular lymphoma (FL) and chronic lymphocytic leukemia...

DDGP Versus SMILE: Comparing Regimens for Extranodal Natural Killer T-Cell Lymphoma

In patients with extranodal natural killer T-cell lymphoma (ENKTL), treatment with the chemotherapy regimen of dexamethasone, cisplatin, gemcitabine, and pegasparaginase (DDGP) improved survival compared...
You Make the Call

You Make the Call: What is the best consolidation therapy for this patient with...

This month, Erin Reid, MD, discusses treatment of primary central nervous system lymphoma. And don't forget to check out next month's clinical dilemma - send...
How I Treat In Brief

How I Treat in Brief: Early Relapsing Follicular Lymphoma

Carla Casulo, MD, and Paul M. Barr, MD, from the Wilmot Cancer Institute at the University of Rochester Medical Center in New York, reviewed...
Advertisement

Current Issue

April 2020, Volume 6, Issue 5

This issue examines current immunization guidelines for patients with hematologic disorders, considers medical education amid the coronavirus pandemic, and more.